Simulect 00078-0331-84
Generic: Basiliximab
- Manufacturer
- Novartis Pharmaceuticals Corporation
- Dosage Form
- Injection, Powder, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- May 12, 1998
- Listing Expires
- December 31, 2026
- Application
- BLA103764
Need to source Simulect? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Basiliximab | 20 mg/5mL |
Drug Class
Interleukin-2 Receptor Blocking Antibody [EPC]Interleukin 2 Receptor Antagonists [MoA]Interleukin 2 Receptor-directed Antibody Interactions [MoA]
Selected Package
00078-0331-84Selected1 VIAL, SINGLE-USE in 1 CARTON (0078-0331-84) / 5 mL in 1 VIAL, SINGLE-USE